The clinical significance of complete class switching defect in Ataxia telangiectasia patients

References

• Chaudhary MW, Al-Baradie RS. Ataxia-telangiectasia: future prospects. Appl Clin Genet. 2014;7:159–167.
   PubMedGoogle Scholar
• Ambrose M, Gatti RA. Pathogenesis of ataxia-telangiectasia: the next generation of ATM functions. Blood. 2013;121(20):4036–4045.
   PubMed Web of Science ®Google Scholar
• Teive HA, Moro A, Moscovich M, et al. Ataxia-telangiectasia - A historical review and a proposal for a new designation: ATM syndrome. J Neurol Sci. 2015;355(1–2):3–6.
   PubMed Web of Science ®Google Scholar
• Moin M, Aghamohammadi A, Kouhi A, et al. Ataxia-telangiectasia in Iran: clinical and laboratory features of 104 patients. Pediatr Neurology. 2007;37(1):21–28.
   PubMed Web of Science ®Google Scholar
• Opal P, Bonilla F. Ataxia-telangiectasia. In: Patterson MC, Stiehm ER, editors. UpToDate: Wolters Kluwer; 2016. [cited 2016 Sept 20]. Available from: http://www.uptodate.com
   Google Scholar
• Micol R, Ben Slama L, Suarez F, et al. Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype. J Allergy Clin Immunol. 2011;128(2):382–9e1.
   PubMed Web of Science ®Google Scholar
• Claret Teruel G, Giner Munoz MT, Plaza Martin AM, et al. Variability of immunodeficiency associated with ataxia telangiectasia and clinical evolution in 12 affected patients. Pediatr Allergy Immunology: Official Publication Eur Soc Pediatr Allergy Immunol. 2005;16(7):615–618.
   PubMed Web of Science ®Google Scholar
• Staples ER, McDermott EM, Reiman A, et al. Immunodeficiency in ataxia telangiectasia is correlated strongly with the presence of two null mutations in the ataxia telangiectasia mutated gene. Clin Exp Immunol. 2008;153(2):214–220.
   PubMed Web of Science ®Google Scholar
• Taylor AM, Lam Z, Last JI, et al. Ataxia telangiectasia: more variation at clinical and cellular levels. Clin Genet. 2015;87(3):199–208.
   PubMed Web of Science ®Google Scholar
• Tangsinmankong N, Wayne AS, Howenstine MS, et al. Lymphocytic interstitial pneumonitis, elevated IgM concentration, and hepatosplenomegaly in ataxia-telangiectasia. J Pediatr. 2001;138(6):939–941.
   PubMed Web of Science ®Google Scholar
• Meyts I, Weemaes C, De Wolf-Peeters C. et al. Unusual and severe disease course in a child with ataxia-telangiectasia. Pediatr Allergy Immunology: Official Publication Eur Soc Pediatr Allergy Immunol. 2003;14(4):330–333.
   PubMed Web of Science ®Google Scholar
• Noordzij JG, Wulffraat NM, Haraldsson A, et al. Ataxia-telangiectasia patients presenting with hyper-IgM syndrome. Arch Dis Child. 2009;94(6):448–449.
   PubMed Web of Science ®Google Scholar
• Aghamohammadi A, Imai K, Moazzami K, et al. Ataxia-telangiectasia in a patient presenting with hyper-immunoglobulin M syndrome. J Investig Allergol Clin Immunol. 2010;20(5):442–445.
   PubMed Web of Science ®Google Scholar
• Ghosh S, Schuster FR, Binder V, et al. Fatal outcome despite full lympho-hematopoietic reconstitution after allogeneic stem cell transplantation in atypical ataxia telangiectasia. J Clin Immunol. 2012;32(3):438–440.
   PubMed Web of Science ®Google Scholar
• Mohammadinejad P, Abolhassani H, Aghamohammadi A, et al. Class switch recombination process in ataxia telangiectasia patients with elevated serum levels of IgM. J Immunoassay Immunochem. 2015;36(1):16–26.
   PubMedGoogle Scholar
• Rawat A, Imai K, Suri D, et al. Ataxia telangiectasia masquerading as hyper IgM syndrome. Indian J Pediatr. 2016;83(3):270–271.
   PubMed Web of Science ®Google Scholar
• Aghamohammadi A, Mohammadinejad P, Abolhassani H, et al. Primary immunodeficiency disorders in Iran: update and new insights from the third report of the national registry. J Clin Immunol. 2014;34(4):478–490.
   PubMed Web of Science ®Google Scholar
• Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunology. 1999;93(3):190–197.
   PubMed Web of Science ®Google Scholar
• Yazdani R, Seify R, Ganjalikhani-Hakemi M, et al. Comparison of various classifications for patients with common variable immunodeficiency (CVID) using measurement of B-cell subsets. Allergol Immunopathol. 2016. doi:10.1016/j.aller.2016.07.001
   PubMed Web of Science ®Google Scholar
• Azarsiz E, Karaca NE, Gunaydin NC, et al. Do elevated serum IgM levels have to be included in probable diagnosis criteria of patients with ataxia-telangiectasia? Int J Immunopathol Pharmacol. 2014;27(3):421–427.
   PubMed Web of Science ®Google Scholar
• Nowak-Wegrzyn A, Crawford TO, Winkelstein JA, et al. Immunodeficiency and infections in ataxia-telangiectasia. J Pediatr. 2004;144(4):505–511.
   PubMed Web of Science ®Google Scholar
• Perreault S, Bernard G, Lortie A, et al. Ataxia-telangiectasia presenting with a novel immunodeficiency. Pediatr Neurol. 2012;46(5):322–324.
   PubMed Web of Science ®Google Scholar
• Pietrucha BM, Heropolitanska-Pliszka E, Wakulinska A, et al. Ataxia-telangiectasia with hyper-IgM and Wilms tumor: fatal reaction to irradiation. J Pediatr Hematol Oncol. 2010;32(1):e28–30.
   PubMedGoogle Scholar
• Durandy A, Kracker S. Immunoglobulin class-switch recombination deficiencies. Arthritis Res Ther. 2012;14(4):218.
   PubMed Web of Science ®Google Scholar
• Suarez F, Lortholary O, Hermine O, et al. Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood. 2006;107(8):3034–3044.
   PubMed Web of Science ®Google Scholar
• Cantaert T, Schickel JN, Bannock JM, et al. Activation-induced cytidine deaminase expression in human B cell precursors is essential for central B cell tolerance. Immunity. 2015;43(5):884–895.
   PubMed Web of Science ®Google Scholar
• Chen L, Guo L, Tian J, et al. Deficiency in activation-induced cytidine deaminase promotes systemic autoimmunity in lpr mice on a C57BL/6 background. Clin Exp Immunol. 2010;159(2):169–175.
   PubMed Web of Science ®Google Scholar
• Soresina A, Meini A, Lougaris V, et al. Different clinical and immunological presentation of ataxia-telangiectasia within the same family. Neuropediatrics. 2008;39(1):43–45.
   PubMed Web of Science ®Google Scholar
• Taylor AM. Ataxia telangiectasia genes and predisposition to leukaemia, lymphoma and breast cancer. Br J Cancer. 1992;66(1):5–9.
   PubMed Web of Science ®Google Scholar
• Pan Q, Petit-Frere C, Lahdesmaki A, et al. Alternative end joining during switch recombination in patients with ataxia-telangiectasia. Eur J Immunol. 2002;32(5):1300–1308.
   PubMed Web of Science ®Google Scholar